Webb30 mars 2024 · Director Nominees Are Ric Kayne, ~4.8% Athira Shareholder, and George Bickerstaff, Former CFO of Novartis Pharma AG. Sends Open Letter to Shareholders Highlighting Urgent Need for Change Following ... Webb30 mars 2024 · Definitive Proxy Statement Definitive Additional Materials ☑ Soliciting Material under § 240.14a-12. Athira Pharma, Inc. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply):
DEFA14A - SEC
Webb4 maj 2024 · BOTHELL, Wash., May 04, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. ATHA, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that leading independent proxy advisory firm Institutional Shareholder Services (ISS) has … Webb5 apr. 2024 · ) 2024 ANNUAL REPORT LETTER FROM THE FORMER CEO " We are optimistic about our strategy and our demonstrated track record of improving the quality of our portfolio and market exposure through acquisition and disposition " activities. Fellow Shareholders: In 2024 we saw the continued resiliency of the multifamily business, … landrat cord bockhop
DEFA14A Form - Additional definitive proxy soliciting materials …
Webb29 juni 2024 · The lawsuits have begun. Barely a week after the CEO of Athira Pharma was placed on temporary leave after allegations of altered images in scientific papers she … Webb5 apr. 2024 · On April 5, 2024, Athira Pharma, Inc. announced that it has filed its definitive proxy statement with the Securities and Exchange Commission for its upcoming annual … Webb16 maj 2024 · We continue to urge shareholders to vote “FOR” Athira’s three director nominees on the WHITE proxy card. The Athira board is highly qualified and actively … landrat cottbus